Veritable, L.P. Moderna, Inc. Transaction History

Veritable, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $76,314 - $103,381	-644 Reduced 11.01%	5,205 $632,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $13,837 - $20,096	-102 Reduced 1.71%	5,849 $898,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $137,202 - $243,436	-1,159 Reduced 16.3%	5,951 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $210,282 - $345,834	1,781 Added 33.42%	7,110 $841,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $57,862 - $87,235	494 Added 10.22%	5,329 $761,000
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $151,246 - $281,119	1,196 Added 32.87%	4,835 $833,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $220,626 - $360,034	-977 Reduced 21.17%	3,639 $924,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $459,998 - $1 Million	2,073 Added 81.52%	4,616 $1.78 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $81,063 - $146,627	624 Added 32.52%	2,543 $598,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $209,516 - $356,895	1,919 New	1,919 $251,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.